0 Commentarii
0 Distribuiri
197 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Alport Syndrome Market is Driven by Gene Therapy AdvancesAlport syndrome is a rare progressive renal disease characterized by inherited defects in type IV collagen, leading to hematuria, proteinuria and eventual kidney failure. The Alport Syndrome Market comprises a diverse portfolio of therapeutics, including symptomatic treatments such as ACE inhibitors, emerging small molecules, biologics targeting fibrosis pathways and novel gene therapies...0 Commentarii 0 Distribuiri 98 Views 0 previzualizare
-
Giant Axonal Neuropathy (GAN) Market is driven by Gene Therapy AdvancementsGiant Axonal Neuropathy (GAN) is a rare, inherited neurodegenerative disorder characterized by progressive nerve damage due to mutations in the GAN gene, leading to impaired intracellular transport within neurons. GAN market offerings primarily comprise gene replacement therapies, viral vectors, and small-molecule modulators designed to correct or compensate for the defective gigaxonin protein....0 Commentarii 0 Distribuiri 188 Views 0 previzualizare
-
Haemophilia Gene Therapy Market Size, Growth & Industry ShareHere's a comprehensive overview of the Hemophilia Gene Therapy Market as of 2025, encompassing recent developments, market drivers, restraints, regional segmentation, emerging trends, top use cases, major challenges, and attractive opportunities. The global haemophilia gene therapy market is expected to grow from USD 350 million in 2022 to USD 5165.26 million by 2030, at a...0 Commentarii 0 Distribuiri 96 Views 0 previzualizare
-
Primary Ciliary Dyskinesia Market is driven by Gene Therapy AdvancementsThe Primary Ciliary Dyskinesia (PCD) Market encompasses diagnostic assays, pharmacological interventions, and innovative gene-based treatments designed to address the structural and functional defects of motile cilia in respiratory epithelium. Products include genetic testing panels, high-resolution microscopy diagnostics, inhaled mucolytics, anti-inflammatory agents, and emerging gene-editing...0 Commentarii 0 Distribuiri 178 Views 0 previzualizare
-
Propionic Acidemia Therapeutic Market is driven by Gene Therapy AdvancementsPropionic acidemia is a rare, inherited metabolic disorder characterized by a deficiency of the propionyl-CoA carboxylase enzyme, leading to toxic metabolite buildup. Therapeutic solutions in this market range from dietary management products and amino acid formulae to innovative enzyme replacement and gene therapy candidates. These products aim to reduce propionate accumulation, stabilize...0 Commentarii 0 Distribuiri 219 Views 0 previzualizare
-
Asia-Pacific Biologics Market Revenue Forecast: Growth, Share, Value, and Trends"Asia-Pacific Biologics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2030 The APAC Biopharmaceuticals Market is witnessing strong growth across multiple sectors, including [industry name], where demand is rising due to innovation and market expansion. Market research data indicates that businesses in the Biotechnology Drug Industry are...0 Commentarii 0 Distribuiri 59 Views 0 previzualizare
-
Bioassay Services Market is driven by rising R&D investmentsThe Bioassay Services Market encompasses a broad range of laboratory testing and analytical solutions designed to evaluate the biological activity, safety, and potency of pharmaceuticals, biotechnology products, and novel compounds. Service offerings include in vitro assays, cell-based screens, high-throughput screening, potency testing, immunoassays, and assay development, which collectively...0 Commentarii 0 Distribuiri 99 Views 0 previzualizare
-
Lipid Nanoparticles Market is Driven by Rising Demand for mRNA VaccinesLipid nanoparticles (LNPs) are microscopic vesicles composed of ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG) derivatives that encapsulate therapeutics such as mRNA, siRNA, and small molecules. These carriers protect nucleic acids from enzymatic degradation, enhance cellular uptake, and ensure targeted delivery across biological barriers. Advantages include...0 Commentarii 0 Distribuiri 135 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek